Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1All patients in the study will be treated with ocrelizumab[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
2Continued Ocrelizumab[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
3OCRELIZUMAB[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[3] 13, 46, 49
4Ocrelizumab (CinnaGen, Iran)[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
5Ocrelizumab (Roche, Switzerland)[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
6Ocrelizumab / rhuMAb 2H7[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
7Ocrelizumab 300 mg[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
8Ocrelizumab 300mg[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
9Ocrelizumab 300mg /10ml[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
10Ocrelizumab 300mg/10 ml[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
11Ocrelizumab 300mg/10ml[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
12Ocrelizumab 500mg[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
13Ocrelizumab 600 mg[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
14Ocrelizumab at home[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
15Ocrelizumab Dose 1[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
16Ocrelizumab Dose 2 and Dose 3[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
17Ocrelizumab IV[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
18Ocrelizumab SC[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
19Ocrelizumabu 200mg----[1] 46
20Ocrelizumabu 50mg----[1] 46
21Other: Observation of Ocrelizumab as Treatment in RRMS Patients[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
22Other: Ocrelizumab[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
23Short-course Ocrelizumab[1] Ocrelizumab[1] D05218 (Name: Ocrelizumab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13